Canada’s Merger Guidelines: Size on Trial

Key Takeaways

• Draft adopts US HHI thresholds as legal presumptions
• Efficiency defence removed; gains rarely affect bureau decisions
• Vertical mergers face same suspicion despite pro‑competitive evidence
• Presumptions risk false positives, stifling investment and innovation
• Other jurisdictions may emulate Canada’s structure‑focused merger regime

Pulse Analysis

The Competition Bureau’s draft guidelines represent a decisive shift toward a rule‑based merger review, borrowing the United States’ post‑transaction Herfindahl‑Hirschman Index (HHI) thresholds of 1,800 and a 100‑point increase, as well as a 30 percent combined market‑share trigger. By turning these metrics into a legal presumption of harm, the Bureau reduces the analytical burden on its investigators but also limits the ability of firms to present nuanced evidence of competitive effects. This structural focus aligns with a broader global trend of seeking administrable standards, yet it departs from the evidence‑centric approach championed by modern antitrust economics.

Economists have long warned that concentration alone does not dictate market outcomes; efficiency gains, innovation, and dynamic competition often accompany higher market shares. The draft’s removal of the statutory efficiencies defence and its stance that such gains are “unlikely to change” the Bureau’s conclusions effectively sidelines a core justification for many mergers. Moreover, the guidelines treat vertical integrations with the same suspicion as horizontal deals, despite a substantial empirical literature showing that vertical mergers frequently enhance consumer welfare through cost reductions and supply‑chain coordination. This inconsistency undermines the credibility of the policy and may discourage beneficial restructuring.

The ramifications extend beyond Canada’s borders. As jurisdictions in Europe, the United States, and Asia grapple with similar debates over structural versus effects‑based enforcement, Canada’s draft could serve as a cautionary example of over‑reliance on presumptions. False‑positive blocks risk eroding investment, stifling innovation, and imposing lasting efficiency losses, while false‑negatives are often self‑correcting as markets evolve. Policymakers worldwide would do well to prioritize robust economic evidence over convenient thresholds, ensuring that merger control protects competition without hampering legitimate business dynamism.